Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23212807 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
A Study of the Effectiveness and Safety of Two Doses of Risperidone in the Treatment of Children and Adolescents With Autistic Disorder
Conditions: Autistic Disorder;   Autism
Interventions: Drug: Placebo;   Drug: Risperidone high dose;   Drug: Risperidone low dose

Indicates status has not been verified in more than two years